Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Status:
Completed

Trial end date:
2005-10-01

Target enrollment:

Participant gender:

This is a double-blind, Phase III study to evaluate the efficacy, safety and PK of MRA in patients with sJIA.

Phase 3

Chugai Pharmaceutical